Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04604418 |
Recruitment Status :
Recruiting
First Posted : October 27, 2020
Last Update Posted : January 11, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The incidence of moderate to severe congenital heart disease (CHD) in the United States is estimated to be 6 per 1000 live-born full term infants. Recent advances in pediatric cardiology, surgery and critical care have significantly improved the survival rates of patients with CHD leading to an increase in prevalence in both children and adults. Children with CHD significant enough to require cardiac surgery frequently also undergo non-cardiac surgical procedures. Analysis of the Pediatric Health Information System database between 2004 and 2012 demonstrated that 41% of children who had undergone surgery to correct CHD in the first year of life also underwent at least one non-cardiac surgery by age 5. With this increased demand for non-cardiac procedures, anesthesiologists, pediatricians and other healthcare providers will encounter patients with repaired or unrepaired CHD and other cardiac diseases in their practice.
However, the information provided by national databases lack granularity and the information from single institutional data is limited.
This project aims to address this knowledge gap in quantifying the risk for cardiac patients coming for noncardiac procedures and identify the health care resource utilization and system to best care for this patient population. To conduct this study, we will create a multi-institutional collaboration between large and small centers to create a unique dataset spanning all the different variables that need to be considered in risk prediction for these patients including patient variables, hospital setting, and providers. The aggregate multiinstitutional data set may be used for benchmarking for national quality improvement efforts.
Condition or disease | Intervention/treatment |
---|---|
Congenital Heart Disease in Children | Other: No intervention. It is observational |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 10000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 1 Month |
Official Title: | Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures |
Actual Study Start Date : | October 1, 2020 |
Estimated Primary Completion Date : | October 31, 2023 |
Estimated Study Completion Date : | December 31, 2023 |

- Other: No intervention. It is observational
No intervention. It is observational
- Mortality [ Time Frame: during the procedure and up to 30-days following the procedure ]Death
- Intensive Care Unit admission [ Time Frame: following the procedure and up to 72 hours ]The postoperative location of the patient is in the intensive care unit unexpectedly
- Postoperative mechanical support [ Time Frame: following the procedure and up to 72 hours ]Patient required a ventilator or noninvasive positive pressure ventilation
- Readmission Cardiac arrest: during the procedure and up to 72 hours Neurologic injury (stroke, seizure) following the procedure and up to 72 hours Renal injury following the procedure and up to 72 hours [ Time Frame: following the procedure and up to 72 hours ]Patient was discharged after the procedure and needed to be readmitted to the hospital is defined as readmission
- Cardiac arrest [ Time Frame: during the procedure and up to 72 hours ]Patient required cardiopulmonary ressuscitation
- Neurologic injury [ Time Frame: Following the procedure and up to 72 hours ]Defined as stroke or seizure by the provider
- Renal Injury [ Time Frame: Following the procedure and up to 72 hours ]Defined based on creatinine and glomerular filtration

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients diagnosed with congenital heart disease and presenting to the participating institution for a noncardiac procedure are included in the study.
All patients will be included.
Inclusion Criteria:
- Males or females ages birth to 21 years.
- Patients diagnosed with congenital heart disease
- Patients undergoing a noncardiac procedure (surgical or nonsurgical)
Exclusion Criteria:
- Patients with congenial heart disease undergoing a cardiac surgical procedure including pacemakers.
- Patients with congenital heart disease undergoing a catheterization(diagnostic or interventional) or an electrophysiology study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04604418
Contact: Viviane Nasr, MD | 617-355-6225 | viviane.nasr@childrens.harvard.edu | |
Contact: Rachel Bernier | 857-218-5348 | Rachel.Bernier@childrens.harvard.edu |
United States, California | |
University of California, Los Angeles | Recruiting |
Los Angeles, California, United States, 90095 | |
Contact: Tiffany Williams, MD, PhD | |
United States, District of Columbia | |
Children's National Medical Center | Recruiting |
Washington, District of Columbia, United States, 20310 | |
Contact: Nina Deutsch, MD | |
United States, Georgia | |
Children's Healthcare of Atlanta - Egleston Hospita | Not yet recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Scott Kolesky, MD | |
United States, Massachusetts | |
Boston Children's Hospital | Recruiting |
Boston, Massachusetts, United States, 02115 | |
Contact: Viviane Nasr, MD | |
United States, Minnesota | |
University of Minnesota Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55455 | |
Contact: Benjamin Kloesel | |
United States, Pennsylvania | |
Children's Hospital of Philadelphia | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Susan Nicolson | |
United States, Tennessee | |
Vanderbilt University Medical Center | Recruiting |
Nashville, Tennessee, United States, 37232 | |
Contact: John Dave Moore, MD | |
United States, Texas | |
Texas Children's Hospital | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Wanda Miller Hance | |
Canada, Ontario | |
Hospital for Sick Kids | Recruiting |
Toronto, Ontario, Canada, M5G 1X8 | |
Contact: David Faraoni, MD, PhD |
Principal Investigator: | Viviane Nasr, MD | Boston Children's Hospital |
Responsible Party: | Viviane Nasr, Associate Professor, Boston Children's Hospital |
ClinicalTrials.gov Identifier: | NCT04604418 |
Other Study ID Numbers: |
IRB-P00035008 |
First Posted: | October 27, 2020 Key Record Dates |
Last Update Posted: | January 11, 2023 |
Last Verified: | January 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Perioperative risk prediction Adverse Postoperative Outcomes |
Heart Diseases Heart Defects, Congenital Cardiovascular Diseases Cardiovascular Abnormalities Congenital Abnormalities |